Mark H. Remus

Laura A. Lydigsen

Eric I. Abraham

Kristine L. Butler

Joshua James

William Murtha

Mary Lafleur

Simon D. Roberts

William C. Shear

Liza M. Walsh

Robert M. Oakes

Elizabeth M. Flanagan

Nitya Anand

Hector D. Ruiz

Jason A. Leonard

Selina M. Ellis

Brianna L. Patterson

Jayita Guhaniyogi

Andria Rae Crisler

Jessica K. Formichella

Isha Agarwal

Rodney Swartz

Vincent Li

Connor S. Romm

ANDA fight escalates as Sandoz's generic XOSPATA® faces five new patents from Astellas over a claimed "proportion of crystals" in the AML cancer drug.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Astellas Pharma US Inc NPE	L4 A
Astellas Pharma Inc NPE	L4 A
Astellas US LLC NPE	L4 A

Name	Ratings
Fish & Richardson	L5 A
William C. Shear	L5 A
Elizabeth M. Flanagan	L5 A
Robert M. Oakes	L5 B
Andria Rae Crisler	L1 C
Cooley LLP	L5 A
Brianna L. Patterson	L2 D
Isha Agarwal	-- -- --
McDermott Will & Emery LLP	L5 C
Jason A. Leonard	L2 B
Jayita Guhaniyogi	L2 E
Nitya Anand	L2 E
Simon D. Roberts	L1 B
Rodney Swartz	-- -- --
Vincent Li	-- -- --
Connor S. Romm	-- -- --
Walsh Pizzi Oreilly Falanga LLPLocal	L3 B
Liza M. Walsh	L4 A
Hector D. Ruiz	L2 A
Selina M. Ellis	L2 E
Jessica K. Formichella	-- -- --

Name	Ratings
Crowell & Moring LLP	L4 A
Mark H. Remus	L4 A
Laura A. Lydigsen	L4 B
Joshua James	L3 A
Mary Lafleur	-- -- --
Hill Wallack LLPLocal	L3 E
Eric I. Abraham	L4 E
William Murtha	L1 E
Kristine L. Butler	-- -- --

2:23-cv-01214

Astellas Pharma Inc v. Sandoz Inc